Dr. David Johnson, M.D.
What this data tells you about Dr. Johnson
Dr. David Johnson is a pain medicine in Destin, FL, with 11 years in practice. Based on federal Medicare data, Dr. Johnson performed 2,918 Medicare services across 1,075 unique beneficiaries.
Between the years covered by Open Payments, Dr. Johnson received a total of $14,215 from 53 pharmaceutical and/or device companies across 434 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Johnson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,366 | $86 | $279 |
| Dexamethasone injection (steroid) | 478 | $0 | $7 |
| Drug screening test | 246 | $58 | $155 |
| Injection, ketorolac tromethamine, per 15 mg | 238 | $0 | $2 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 132 | $147 | $391 |
| Drug injection, under skin or into muscle | 82 | $10 | $38 |
| New patient office visit (45-59 min) | 64 | $124 | $465 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 38 | $223 | $617 |
| Contrast dye for imaging, lower concentration | 31 | $0 | $2 |
| Injection, midazolam hydrochloride, per 1 mg | 28 | $0 | $10 |
| X-ray of lower and sacral spine, minimum of 4 views | 25 | $40 | $200 |
| Injection of trigger points, 3 or more muscles | 22 | $44 | $205 |
| Injection, methylprednisolone acetate, 40 mg | 21 | $6 | $15 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 18 | $106 | $2,528 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 18 | $489 | $1,502 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 18 | $269 | $892 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 17 | $60 | $1,553 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 17 | $28 | $50 |
| Injection of drug or substance into vein | 16 | $27 | $98 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $36 | $124 |
| Injection of additional new drug or substance into vein | 14 | $11 | $101 |
| Injection, fentanyl citrate, 0.1 mg | 13 | $1 | $1 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
8.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Johnson is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 11%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Johnson experienced with office visit, established patient (30-39 min)?
Does Dr. Johnson receive payments from pharmaceutical companies?
How do Dr. Johnson's costs compare to other pain medicines in Destin?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology